Epidermal Growth Factor Receptor (EGFR) Cell Expression During Adjuvant Treatment After Transurethral Resection for Non-Muscle-Invasive Bladder Cancer: A New Potential Tool to Identify Patients at Higher Risk of Disease Progression

Antonina Cangemi, Vincenzo Serretta, Rosalinda Allegro, Antonio Russo, Andrea Cocci, Fabrizio Di Maida, Riccardo Tellini, Simone Sforza, Andrea Mari, Lorenzo Masieri, Andrea Minervini, Marco Carini, Cristina Scalici Gesolfo

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

The aim of the study was to investigate the feasibility of Epidermal Growth Factor Receptor (EGFR) measurement in bladder washings of patients affected by non-muscle-invasive bladder cancer (NMIBC) and its prognostic role in identifying risk subgroups and predicting disease recurrence and progression.
Original languageEnglish
Number of pages0
JournalClinical Genitourinary Cancer
Publication statusPublished - 2019

All Science Journal Classification (ASJC) codes

  • Oncology
  • Urology

Fingerprint Dive into the research topics of 'Epidermal Growth Factor Receptor (EGFR) Cell Expression During Adjuvant Treatment After Transurethral Resection for Non-Muscle-Invasive Bladder Cancer: A New Potential Tool to Identify Patients at Higher Risk of Disease Progression'. Together they form a unique fingerprint.

  • Cite this